Concepedia

Author

ES Daar

Harbor–UCLA Medical Center

Also Known As

ES Daar

2

Publications

73

Citations

2

H-Index

0

Concepts

All Affiliations

Harbor–UCLA Medical CenterThe Lundquist Institute
ED

About

ES Daar is an author at Harbor–UCLA Medical Center.

ES Daar

×

2

Publications

73

Citations

2

H-Index

YearCitations

Switching to coformulated rilpivirine (<scp>RPV</scp>), emtricitabine (<scp>FTC</scp>) and tenofovir alafenamide from either <scp>RPV</scp>,<scp> FTC</scp> and tenofovir disoproxil fumarate (<scp>TDF</scp>) or efavirenz, <scp>FTC</scp> and <scp>TDF</scp>: 96‐week results from two randomized clinical trials

D Hagins, Chloe Orkin, ES Daar,

HIV Medicine

2018

47

The prevalence of transmitted antiretroviral drug resistance in treatment‐naïve patients and factors influencing first‐line treatment regimen selection

H.‐Y. HUANG, ES Daar, Barnaby Edward Young,

HIV Medicine

2008

26

Page 1